RWD136 Real-World Use of Biologic Disease-Modifying Anti-Rheumatic Drugs in US Patients with Ankylosing Spondylitis: Persistence, Factors Associated with Discontinuation, and Dosing Patterns
Abstract
Authors
M. Dubreuil J.A Walsh A. Deodhar L.S Gensler J.R Curtis S. Anjohrin O. Pilipczuk M. Feudjo Tepie S. Beaty M. Mørup V. Taieb S. Welby